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Background: We tested the hypothesis that the apical myocardial mechanics differ from those of other ventricular
segments in hypertensive patients with and without apical hypertrophic cardiomyopathy (ApHCM).
Methods: We retrospectively studied hypertensive patients with and without ApHCM. Left ventricular longitudinal,
circumferential, and radial strains were examined by two-dimensional speckle-tracking echocardiography at the
basal, middle, and apical walls of the parasternal short-axis and apical 2-, 3- and 4-chamber views.
Results: Fourteen consecutive patients with hypertension and ApHCM and 14 patients with hypertension without
ApHCM were studied. Lower mitral annular peak systolic velocity and greater diastolic dysfunction were present in
hypertensive patients with ApHCM than in hypertensive patients without ApHCM. Compared with hypertensive patients
without ApHCM, hypertensive patients with ApHCM had significantly lower apical longitudinal (−13.9% vs −21.9%,
p = 0.010) and radial strains (4.4% vs 11.5%, p = 0.017) without the base-to-apex gradient. The global longitudinal
(−15.6% vs −18.8%, p = 0.027) and circumferential strains (−16.1% vs −19.2%, p = 0.019) were significantly lower in
hypertensive patients with ApHCM than in hypertensive patients without ApHCM. Among systolic parameters, the
global longitudinal strain was independently associated with hypertension with ApHCM (odds ratio, 1.457; 95%
confidence interval, 1.002–2.119; p = 0.049).
Conclusions: Reduced apical longitudinal and radial strains without a base-to-apex gradient were present in
hypertensive patients with ApHCM. The global longitudinal strain was independently associated with ApHCM in
hypertensive patients.
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Apical hypertrophic cardiomyopathy (ApHCM), in which
the myocardial wall thickening is localized at the apex of
the left ventricle, is comparatively rare in western countries
in comparison with Asia [1,2]. ApHCM is described as an
electrocardiographic pattern of giant negative T waves and
an angiographic feature of end-diastolic left ventricular
cavity structure resembling an ‘ace of spades’ [3,4]. It has
a benign clinical course in terms of cardiovascular mortal-
ity [1,2,5,6]; however, it may be associated with serious* Correspondence: hmj1447@cgmh.org.tw
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reproduction in any medium, provided the orcomplications, such as myocardial infarction and arrhyth-
mias [2,6]. Less benign clinical outcomes of patients with
ApHCM and hypertension have been observed recently
[7]. The presentation of ApHCM in the setting of chronic
hypertension is recognized as an important issue because
an accurate diagnosis has an impact on prognosis and
management [8].
Echocardiographic strain imaging is an innovative ap-
proach recently developed for the assessment of left ven-
tricular myocardial mechanics [9]. Myocardial strain can
be determined using tissue Doppler imaging or two-
dimensional speckle tracking. Doppler-based techniques
are limited by the angle-dependence of the signal, pre-
cluding the assessment of apical left ventricular function.. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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thogonal components of strain independent of the insona-
tion angle because it tracks deformation between acoustic
markers in the ultrasonic image in two dimensions [9].
Few studies have addressed regional myocardial mechan-
ics in patients with ApHCM [10-12], and 2-dimensional
deformation imaging studies of hypertensive patients with
and without ApHCM are lacking. For the present study,
we hypothesized that regional myocardial mechanics of
the apex differed from those of the other ventricular seg-
ments in hypertensive patients with and without ApHCM.
Therefore, in this retrospective 2-dimensional echocardio-
graphic study, we investigated left ventricular deformation
in hypertensive patients with and without ApHCM.
Methods
Study population
The study patients were identified through the cardiac
care outpatient clinic of Chang Gung Memorial Hospital,
Keeling, a tertiary referral hospital. We retrospectively
studied the clinical outcomes of consecutive patients with
a new diagnosis of hypertension and ApHCM between
August 2011 and September 2012. Data were abstracted on
demographic characteristics, coronary risk factors, symp-
toms, and findings on physical examination at the time of
presentation, and diagnosis of ApHCM, as well as the most
recent follow-up visit. The control group consisted of age-
matched asymptomatic patients who had hypertension,
but no ApHCM. The study was approved by the Research
Ethics Review Board of Chang Gung Memorial Hospital
(101-2038B).
Diagnostic criteria
The echocardiographic inclusion criteria for ApHCM
were the following: 1) asymmetric left ventricular hyper-
trophy confined primarily to the left ventricular apex
below the papillary muscle level; 2) apical wall thickness ≥
15 mm; 3) a ratio of maximal apical to posterior wall thick-
ness ≥ 1.5. Patients were excluded if they had one of fol-
lowing: 1) a severe valvular lesion; 2) sustained atrial or
ventricular arrhythmias; 3) prior percutaneous intervention;
4) prior cardiac surgery; 5) prior myocardial infarction; 6)
pericardial disease; 7) immunological disease; 8) active in-
fection; 9) moderate to severe anemia or 10) hyper- or
hypothyroidism.
Clinical data
Current smoking status was defined as having smoked at
least half of a pack of cigarettes per year and having
smoked at least one cigarette within 3 weeks before enroll-
ment. Diabetes mellitus was defined as a fasting glucose
level ≥ 126 mg/dL or use of hypoglycemic medication. Hy-
percholesterolemia was defined as a low-density lipopro-
tein level ≥ 130 mg/dL in a fasting blood sample or use ofa statin medication. Hypertension was defined as use of
antihypertensive medications or a blood pressure > 140/
90 mmHg. Ischemic heart disease was confirmed by 1)
coronary angiography, with ≥ 50% diameter stenosis in
one or more coronary vessels after administration of
intracoronary nitroglycerin or 2) a 201thallium myocar-
dial perfusion scan showing reversible/irreversible per-
fusion defects. Glomerular filtration rate was estimated
using the Modification of Diet in Renal Disease Study 4-
variable equation [13].Electrocardiography
Electrocardiograms were analyzed for the presence of left
ventricular hypertrophy according to the Sokolow-Lyon cri-
teria [14]. The corrected QT interval was measured in lead
V2 [15]. ‘Giant’ T wave negativity was defined as a negative
T wave voltage ≥ 1 mV (≥ 10 mm) in any of the leads.Standard echocardiography
All echocardiograms were performed by two experienced
physicians (M-J and N-I) who used a commercially available
system (Vivid E9, General Electric-Vingmed, Milwaukee,
Wisconsin). Images were obtained with patients in the left
lateral decubitus position at end-expiration. All standard
measurements were obtained in the parasternal long- and
short-axis views; apical 4-chamber, 2-chamber, and long-
axis views. Two-dimensional and color Doppler imaging
were performed to screen for wall motion abnormalities,
mitral annulus calcification, and valvular stenosis or regur-
gitation. For pulsed-tissue Doppler studies, a 2-mm sam-
pling volume was used from the apical 4-chamber view in
the septal mitral annulus. The maximal apical wall thick-
ness was obtained as the average of the measurements in
the apical 4-chamber and 2-chamber views at end-diastole.
Left ventricular ejection fraction and stroke volume were
obtained by quantitative 2-dimensional ultrasonography as
previously described [16]. Transmitral pulsed-wave Doppler
and tissue Doppler were recorded in the apical 4-chamber
view. Pulsed-wave Doppler velocities of the pulmonary ven-
ous flow were obtained in the right upper pulmonary vein.
Tissue Doppler imaging of the septal mitral annulus was
used to measure mitral annular velocities in peak systole
(Sm) and in early (Em) and late diastole (Am). Diastolic
function was categorized as: normal, impaired relaxation,
pseudonormalized filling, and restrictive filling [17]. The
time interval from the end to the onset of the mitral annu-
lar velocity pattern during diastole (am) and the duration of
the S-wave (bm) were measured and used to calculate the
myocardial performance index as (am-bm)/bm [18]. The
isovolumic relaxation time (IVRT) was calculated as the
time interval between Sm and Em, and the isovolumic con-
traction time was calculated as the time interval between
Am and Sm.
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Two-dimensional strain analysis was performed offline
using Echopac software, version 110.1.2 (General Electric-
Vingmed) by two independent observers who were un-
aware of the patients’ conditions. All strain images were
obtained at a frame rate of 60–90 frames/s. For each of
the three short-axis views, the sampling points were
placed manually along the endocardium at the left ven-
tricular base, middle, and apex during end-systole. For
each of the 2-, 3- and 4-chamber views, three sampling
points were placed manually at the septal mitral annulus,
lateral corner, and apical endocardium. A region of inter-
est was then generated by the software covering the myo-
cardial thickness along the entire left ventricular wall. The
region of interest was adjusted manually to ensure that
the inner margin conformed to the entire left ventricular
endocardial border and that it included the entire thick-
ness of the left ventricular myocardium. The software sub-
sequently identified the tissue speckles and tracked their
movement frame-by-frame throughout the cardiac cycle.
The left ventricular wall was divided into six segments
arranged circumferentially at the basal, middle, and apical
levels. The software algorithm then calculated longitudinal,
circumferential, and radial strains for each segment in
graphical form, with automated measurements recorded
in tabular form. Peak systolic longitudinal, circumferential,
and radial strains for each segment were recorded: the
values for all the myocardial segments for each patient
were averaged to obtain the global values. End-systole was
defined by the time of aortic valve closure and end-
diastole was defined by the time of mitral valve closure by
Doppler ultrasonography from the apical 4-chamber view.
Reproducibility
Inter- and intra-observer variability were assessed by two
experienced physicians evaluating the raw data of five pa-
tients with hypertension and five patients with hyperten-
sion and ApHCM in a blinded manner at baseline and at
1 week later. They were instructed to measure strain pa-
rameters independently from each other.
Statistical analyses
The sample size calculation was based on the differences
in the mean between the two groups with equal sample
size, pre-specified 5% type I error, and 90% power (Z1-β =
1.00). We performed a sample size calculation using Power
Analysis Statistical Software (PASS 6.0, license 13451701;
NCSS Inc., Kaysville, Utah). A sample size of 12 subjects
in the control and ApHCM groups would achieve 90%
power to detect a difference of 20% strain between the null
hypothesis that both group differences in the means are
0.00 and the alternative hypothesis that the differences in
means between the two groups is 20% strain, with a 2-
sided test and a significance level of 0.05.Continuous variables with skewed distributions and p
values of < 0.05 by Kolmogorov-Smirnov testing were
presented as medians (25th, 75th percentiles), and those
not skewed were expressed as means ± standard devia-
tions. For normally distributed continuous variables, a
two-sample unpaired t-test was performed. For variables
with skewed distributions, the Wilcoxon rank sum test and
Fisher’s exact test were used. Receiver-operating character-
istic curves were constructed, and areas under curve were
calculated. Sensitivities and specificities were determined
for the ability to identify ApHCM. Reproducibilities (both
interobserver and intra-observer variability) of speckle-
tracked echocardiographic parameters were tested using
the Bland-Altman statistic. A p-value of < 0.05 was consid-
ered statistically significant. Statistical analyses were per-
formed using SPSS software version 15.0 for Windows
(Chicago, Illinois).Results
Clinical and electrocardiographic characteristics
Fourteen consecutive patients with hypertension and
ApHCM and 14 patients with hypertension without Ap
HCM were studied. The clinical and electrocardiographic
characteristics of the two groups are compared in Table 1.
Nearly half of the hypertensive patients with ApHCM
presented with dyspnea on exertion and one-fifth of the
patients were asymptomatic. All of the hypertensive pa-
tients with ApHCM experienced mild-to-moderate dys-
pnea (New York Heart Association functional class < 3).
As compared with hypertensive patients without ApHCM,
hypertensive patients with ApHCM had a higher body
mass index, lower diastolic blood pressure, and lower esti-
mated glomerular filtration rate. Hypertensive patients
with ApHCM had higher prevalences of left ventricular
hypertrophy and giant negative T wave (Figure 1A), and
larger maximal T wave inversion than in the hypertensive
patients without ApHCM.Standard echocardiography
The standard echocardiographic parameters of the two
groups are compared in Table 2. Left ventricular wall
thickness, apex thickness (Figure 1B, C), and left atrial
diameter were greater in hypertensive patients with
ApHCM than in hypertensive patients without ApHCM.
Hypertensive patients with ApHCM had lower Sm, a
higher myocardial performance index, longer IVRT, and
greater prevalence of left ventricular diastolic dysfunc-
tion. Although lower diastolic blood pressure and larger
body mass index were present in hypertensive patients
with ApHCM, left ventricular systolic (lower Sm) and
diastolic (dilated left atrium, longer IVRT, and higher dia-
stolic function grade) function were more impaired in these
patients than in hypertensive patients without ApHCM,
Table 1 Comparison of clinical and electrocardiographic characteristics between hypertensive patients with and
without apical hypertrophic cardiomyopathy (ApHCM)
Hypertension with ApHCM (n = 14) Hypertension without ApHCM (n = 14) p
Age (years) 62 ± 11 63 ± 12 0.784
Female (%) 36 57 0.449
BMI (kg/m2) 30 (27, 32) 25 (23, 28) 0.013
Systolic blood pressure, mmHg 130 ± 12 138 ± 10 0.069
Diastolic blood pressure, mmHg 70 ± 8 77 ± 7 0.030
Heart rate (beats/min) 66 ± 11 67 ± 10 0.740




Dyspnea on exertion 43
Asymptomatic 21
NYHA class at presentation (%)
I 43
II 57
III and IV 0
Smoking (%) 50 43 1.000
Diabetes (%) 29 21 1.000
Ischemic heart disease (%) 21 14 1.000
Dyslipidemia (%) 57 36 0.449
Estimated GFR (ml/min/m2) 70 ± 25 93 ± 27 0.029
Low-density lipoprotein (mg/dL) 111 ± 42 108 ± 29 0.796
Medications (%)
β-blockers 43 43 1.000
ACEI/ARB 64 60 1.000
Calcium antagonists 86 50 0.103
Diuretics 29 7 0.326
Nitrates 21 7 0.596
Aspirin 21 36 0.678
Statins 36 36 1.000
Electrocardiography
LV hypertrophy (%) 86 21 0.002
Giant negative T waves (%) 50 0 0.006
Maximal T wave inversion (mm) 10.3 (7.3, 15.0) 0.5 (0, 2.1) < 0.001
Corrected QT interval (ms) 446 ± 33 428 ± 17 0.081
Data are presented as means ± SD, number, or medians (25th, 75th percentiles).
ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; BMI = body mass index; GFR = glomerular filtration rate; LV = left
ventricular hypertrophy.
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on left ventricular systolic and diastolic function.
Two-dimensional speckle-tracking echocardiography
Table 3 depicts the speckle-tracking echocardiographic
parameters of the two groups. Overall (Figure 1 D, E), theglobal longitudinal and circumferential strains decreased,
and apical, but not basal and middle, longitudinal, and
radial strains, decreased in hypertensive patients with Ap
HCM compared with hypertensive patients without Ap
HCM. From the segmental view, the apical longitudinal
and radial strains consistently decreased in hypertensive
Figure 1 A representative patient with hypertension and ApHCM. (A) The 12-lead resting electrocardiogram shows left ventricular hypertrophy
with a giant negative T-wave in the V2–4 leads. Parasternal long-axis echocardiographic images show apical hypertrophy (double arrowheads) at the
end-diastolic phase (B) and apical obstruction (arrow) at the end-systolic phase (C). Representative examples of global longitudinal strain (GLS) images
in hypertensive patients with ApHCM (D, GLS = −17.3%) and without ApHCM (E, GLS = −18.3%). The GLS decreases without a base-to-apex gradient
in hypertensive patients with ApHCM as compared with hypertensive patients without ApHCM.
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without ApHCM. Furthermore, the apical longitudinal and
radial strains in hypertensive patients with ApHCM did not
show a base-to-apex gradient as in hypertensive patients
without ApHCM (Figure 2). Longitudinal strain of the lat-
eral and anterior walls decreased in all segments, whereas
the longitudinal strain of the septal and inferior walls
decreased only in the apical segment among hyperten-
sive patients with ApHCM compared with hypertensive
patients without ApHCM. Circumferential strain decreased
only in the apical lateral and anterior walls among hyper-
tensive patients with ApHCM compared with hypertensive
patients without ApHCM. Radial strain decreased in all ap-
ical walls, except the septal and inferior walls in hyperten-
sive patients with ApHCM compared with hypertensive
patients without ApHCM. Overall, apical anterior and
lateral wall strains decreased consistently irrespective of
the measurement.Association with ApHCM
Our final multivariate model controlled for systolic parame-
ters with p < 0.10, i.e., Sm, left ventricular global longitu-
dinal, circumferential, and radial strains. After controlling
for these covariates, multivariate analysis showed that global
longitudinal strain was an independent predictor of hyper-
tension with ApHCM (Table 4). Harrell’s C statistic of the
multivariate model showed a strong discriminative power
[0.862, 95% confidence interval (CI): 0.716–1.008, p =
0.001]. The cut-off value for left ventricular global longitu-
dinal strain that predicted the presence of hypertension
with ApHCM was > −16.8% according to receiver-operator
characteristic analysis (area under curve = 0.74 ± 0.10, 95%
CI: 0.55–0.93, p = 0.029, Figure 3). The sensitivity, specifi-
city, positive and negative predictive values, and positive
likelihood ratio for this ratio in detecting hypertension with
ApHCM in our cohort were 64%, 93%, 90%, 72%, and 9.0,
respectively.
Table 2 Comparison of standard echocardiographic parameters between hypertensive patients with and without apical
hypertrophic cardiomyopathy (ApHCM)
Hypertension with ApHCM Hypertension without ApHCM p
Interventricular septum thickness (mm) 12.9 ± 2.7 10.2 ± 2.3 0.007
Posterior wall thickness (mm) 10.8 ± 2.6 8.3 ± 1.9 0.008
Apex thickness (mm) 23.8 (22.7, 29.9) 8.6 (7.8, 9.2) < 0.001
LV end-diastolic diameter (mm) 50 ± 5 50 ± 4 0.975
LV end-systolic diameter (mm) 28 ± 8 31 ± 3 0.255
LV end-diastolic volume index (ml/m2) 29 ± 12 38 ± 16 0.086
LV end-systolic volume index (ml/m2) 9 ± 4 12 ± 7 0.201
Stroke volume index (ml/m2) 20 ± 9 26 ± 10 0.083
LV ejection fraction (%) 68 ± 8 69 ± 8 0.697
LA end-systolic diameter (mm) 47 ± 6 39 ± 5 0.001
Mitral E/A ratio 1.00 ± 0.50 0.82 ± 0.20 0.226
Sm (cm/s) 5.6 ± 1.5 6.9 ± 1.5 0.030
Myocardial performance index 0.76 ± 0.31 0.56 ± 0.12 0.039
IVRT (ms) 128 ± 32 100 ± 21 0.012
IVCT (ms) 68 ± 22 65 ± 18 0.681
E/Em 15.1 ± 4.3 13.0 ± 2.6 0.128
LV diastolic function, grade 0.045
Normal 0 2
Impaired relaxation, I 10 12
Pseudonormalized filling, II 4 0
Restrictive filling, III 0 0
Data are presented as means ± SD, number, or median (25th, 75th percentiles).
A = atrial contraction; D = diastolic; E = rapid filling; Em =mitral annular early diastolic velocity; IVRT = isovolumic relaxation time; IVCT = isovolumic contraction
time; LA = left atrial; LV = left ventricular; Sm =mitral annular peak systolic velocity.
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The interobserver and intra-observer agreements con-
cerning left ventricular global longitudinal strain (0.53
and −0.37 for bias, respectively), circumferential strain
(−0.35 and 0.17 for bias, respectively), and radial strain
(−0.66 and −0.43 for bias, respectively) were satisfactory
(Figure 4).
Discussion
Compared with hypertensive patients without ApHCM,
those with hypertension and ApHCM had 1) more left ven-
tricular systolic and diastolic dysfunctions; 2) decreased ap-
ical longitudinal and radial strains without a base-to-apex
gradient; 3) constantly reduced apical anterior and lateral
wall strains irrespective of strain measurement method; 4)
independently reduced global longitudinal deformation. In-
terestingly, these results were obtained from patients with
normal left ventricular ejection fractions, highlighting
the evidence that alterations of myocardial strain are
early contractile abnormalities in hypertensive patients
with ApHCM.
The outcomes of patients with ApHCM are not as be-
nign as previously thought [1,2,5,6]. Moon et al. [7] foundthat the presence of hypertension was the most negative
determinant of poor clinical outcomes in patients with
ApHCM. Consistent with this report, we also found that
ApHCM conferred a negative impact on hypertensive
patients in terms of systolic and diastolic functions. A
reduced Sm, which indicates impaired myocardial con-
tractility, could represent consequent subclinical systolic
dysfunction despite a normal left ventricular ejection frac-
tion. Furthermore, our patients had diastolic dysfunction
as evidenced by a dilated left atrium, longer IVRT, and
higher diastolic function grade as noted by others [7,19],
which suggests that local apical hypertrophy could affect
global left ventricular diastolic function. With impaired
left ventricular systolic and diastolic functions of ApHCM,
the left ventricular stroke volume is consequently reduced
despite a normal left ventricular ejection fraction.
In hypertrophic cardiomyopathy patients, longitudinal
strain is reduced heterogeneously as assessed by magnetic
resonance imaging tagging [20]. Similarly, Yang et al. [12]
also found that longitudinal strain is reduced in both septal
hypertrophic cardiomyopathy and ApHCM. The subendo-
cardial region contributes primarily to the longitudinal me-
chanics of the left ventricle. Therefore, the subendocardial
Table 3 Comparison of segmental values in each left
ventricular wall for left ventricular strain in hypertensive











Septal −15.8 ± 6.3 −15.8 ± 4.2 0.983
Lateral −11.5 ± 7.0 −16.6 ± 4.7 0.029
Inferior −18.7 ± 6.0 −20.0 ± 5.0 0.552
Anterior −11.1 ± 4.1 −15.3 ± 4.0 0.012
Posterior −17.1 ± 8.5 −18.9 ± 6.4 0.534
Anteroseptal −8.7 (−6.7, -14.4) −17.1 (−14.3, -21.7) 0.009
All walls −14.4 (−11.8, -16.1) −17.6 (−15.5, -19.2) 0.013
Middle
Septal −15.8 ± 5.8 −19.0 ± 2.9 0.071
Lateral −11.6 ± 5.6 −16.2 ± 3.4 0.016
Inferior −15.2 ± 10.1 −20.8 ± 3.7 0.062
Anterior −11.8 (−6.7, -14.4) −17.8 (−12.6, -20.8) 0.002
Posterior −17.3 ± 7.7 −20.2 ± 4.4 0.227
Anteroseptal −13.7 (−8.1, -17.9) −18.7 (−13.9, -18.7) 0.016
All walls −13.5 (−10.5, -18.8) −18.5 (−17.4, -20.8) 0.009
Apical
Septal −15.0 (−12.8, -22.5) −25.2 (−21.8, -29.2) 0.001
Lateral −14.3 (−10.6, -20.0) −21.1 (−17.0, -24.8) 0.005
Inferior −12.6 (−7.2, -22.9) −22.2 (−19.0, -27.2) 0.011
Anterior −12.5 ± 8.5 −21.8 ± 7.6 0.005
Posterior −18.9 ± 8.2 −22.4 ± 5.4 0.201
Anteroseptal −17.4 ± 9.3 −22.1 ± 7.1 0.141
All walls −13.9 (−10.6, -23.3) −21.9 (−19.2, -27.4) 0.010
All segments −15.6 (−12.1, -19.2) −18.8 (−17.7, -21.9) 0.027
Circumferential strain (%)
Basal
Septal −19.4 ± 9.5 −22.9 ± 6.7 0.269
Lateral −11.0 ± 5.5 −12.9 ± 5.7 0.375
Inferior −16.5 ± 4.5 −17.2 ± 5.5 0.685
Anterior −14.6 ± 8.0 −16.2 ± 6.9 0.584
Posterior −13.2 ± 5.5 −13.7 ± 6.1 0.816
Anteroseptal −19.8 ± 9.0 −22.1 ± 4.8 0.418
All walls −15.7 ± 3.9 −17.5 ± 3.0 0.195
Middle
Septal −22.5 ± 5.6 −26.2 ± 4.0 0.051
Lateral −14.7 ± 6.2 −13.5 ± 4.8 0.560
Inferior −18.6 ± 4.8 −17.3 ± 5.9 0.544
Anterior −18.8 ± 6.0 −17.3 ± 6.3 0.502
Posterior −14.5 ± 6.1 −13.4 ± 8.0 0.682
Table 3 Comparison of segmental values in each left
ventricular wall for left ventricular strain in hypertensive
patients with and without apical hypertrophic
cardiomyopathy (ApHCM) (Continued)
Anteroseptal −21.9 ± 5.2 −26.3 ± 4.7 0.026
All walls −17.4 ± 3.2 −17.8 ± 1.9 0.687
Apical
Septal −19.1 ± 7.2 −18.6 ± 6.9 0.863
Lateral −16.9 ± 8.2 −25.6 ± 9.0 0.013
Inferior −20.0 ± 8.2 −21.7 ± 6.3 0.532
Anterior −14.5 ± 8.0 −24.7 ± 9.7 0.006
Posterior −19.3 ± 8.5 −24.6 ± 7.4 0.093
Anteroseptal −16.0 ± 6.4 −20.0 ± 8.1 0.160
All walls −17.6 ± 7.1 −22.5 ± 7.4 0.085
All segments −16.1 (−14.9, -19.5) −19.2 (−18.0, -20.3) 0.019
Radial strain (%)
Basal
Septal 28.4 ± 17.1 40.2 ± 19.5 0.102
Latera 29.6 ± 17.9 39.6 ± 21.8 0.197
Inferior 29.9 ± 19.7 42.6 ± 19.9 0.101
Anterior 27.5 ± 14.3 34.3 ± 20.0 0.309
Posterior 30.8 ± 20.3 43.1 ± 21.5 0.132
Anteroseptal 29.1 ± 15.8 33.9 ± 17.6 0.457
All walls 29.2 ± 16.0 39.0 ± 18.5 0.149
Middle
Septal 40.0 ± 17.7 40.3 ± 14.0 0.962
Lateral 40.3 ± 18.9 37.8 ± 15.5 0.706
Inferior 40.8 ± 17.5 40.0 ± 16.7 0.902
Anterior 38.3 ± 20.3 40.8 ± 16.6 0.722
Posterior 40.9 ± 18.0 38.5 ± 17.3 0.723
Anteroseptal 38.3 ± 18.5 41.1 ± 15.1 0.666
All walls 39.8 ± 18.0 39.8 ± 13.3 0.998
Apical
Septal 6.7 ± 5.2 11.8 ± 11.7 0.147
Lateral 4.1 (1.3, 12.1) 12.8 (10.7, 17.0) 0.008
Inferior 6.4 ± 5.5 12.1 ± 11.0 0.093
Anterior 3.7 (0.8, 11.2) 12.9 (10.7, 20.9) 0.005
Posterior 4.5 (1.7, 12.4) 11.4 (9.9, 15.4) 0.024
Anteroseptal 4.0 (1.7, 10.8) 11.0 (9.2, 14.2) 0.033
All walls 4.4 (1.7, 12.2) 11.5 (10.1, 14.7) 0.017
All segments 25.0 ± 9.4 30.6 ± 7.6 0.097
Data are presented as means ± SD or median (25th, 75th percentiles).
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that are more commonly observed in hypertrophic cardio-
myopathy. Abnormal myocardial capillary density and
microvascular dysfunction occur in the hypertrophic myo-
cardial segments of patients with ApHCM [19,21]. These
Figure 2 The base-to-apex gradients of longitudinal.
(A), circumferential (B), and radial (C) strains are not observed in
hypertensive patients with ApHCM (black bars) compared with
hypertensive patients without ApHCM (white bars). a = apex;
b = base; m =middle; *p < 0.05 versus b; **p < 0.05 versus m.
Table 4 Multivariable logistic regression analysis of left
ventricular systolic parameters for prediction of apical
hypertrophic cardiomyopathy in hypertensive patients
Multivariate
Odds ratio 95% CI p
Sm 0.391 0.145-1.056 0.064
Global longitudinal strain 1.457 1.002-2.119 0.049
Global circumferential strain 1.560 0.912-2.669 0.105
Global radial strain 0.952 0.818-1.107 0.533
Sm =mitral annular peak systolic velocity.
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endocardial layer, which may result in the formation of fi-
brotic tissue in the hypertrophic apex of hearts with
ApHCM [22]. Normally, left ventricular strains are hetero-
geneous: both the longitudinal and circumferential strains
are higher in the apical and middle segments than basal
segments. Continuous shortening in the longitudinal and
circumferential direction would result in thickening in the
radial direction for mass conservation. Therefore, the apical
radial strain is lower, but the longitudinal and circumferen-
tial strains are higher than in the basal segment [23,24]. We
also found similar findings with further reduced apical ra-
dial strain in hypertensive patients with ApHCM than in
hypertensive patients without ApHCM. These findings sug-
gest that the hypertrophic apex of hearts with ApHCM is
characterized by both morphological and functional abnor-
malities, which cause the disappearance of the base-to-apex
gradient. In addition, we also observed attenuated longitu-
dinal values in the middle ventricular segments relative
to the basal segments, in contrast to the base-to-apex gradi-
ent in longitudinal values reported by Sun et al. [23]. This
finding appears to indicate that the pathologic ventricular
hypertrophy extends beyond the apex into the middle
and basal ventricular parts of hearts in cases of ApHCM
[22,25].
With characteristic insonation angle independence, 2-
dimensional speckle tracking echocardiography allows re-
searchers to investigate cardiac mechanics not only globally,
but also regionally; as a result, it is uniquely suited for
the assessment of left ventricular apical deformation such
as that of ApHCM. In the present study, hypertensive pa-
tients without ApHCM (control group) had lower than
normal strain values, which is similar to the findings of
Mizuguchi et al. [26]. Based on the comorbidity of ApHCM
in hypertensive patients, the left ventricular mechanics are
worse than that in hypertensive patients without ApHCM.
Inoue et al. [27] found that left ventricular free walls, as well
as hypertrophic septa, are dysfunctional in patients with
hypertrophic cardiomyopathy, indicating the importance of
the lateral wall function and structure. We also observed
constantly reduced apical anterior and lateral wall strains ir-
respective of strain measurement method, suggesting that
the left ventricular apical free walls are the most dysfunc-
tional. The global 2-dimensional longitudinal strain is a sur-
rogate parameter of myocardial fibrosis and cardiac events
in patients with hypertrophic cardiomyopathy [28]. Consist-
ent with another study involving patients with decreased
functional capacity, [29] we noted that global longitudinal
strain was independently associated with hypertension
with ApHCM, suggesting that global longitudinal strain is
a valuable marker in hypertensive patients with ApHCM.
Subendocardial dysfunction is partly responsible for the
association because the subendocardial region contributes
primarily to the longitudinal strain, and the region is most
Figure 3 Receiver-operator characteristic analysis. The optimum cut-off value for left ventricular global longitudinal strain to differentiate the
presence of hypertension with ApHCM was −16.8%; the sensitivity and specificity were 64% and 93%, respectively. The area under curve was 0.74 ± 0.10
(95% CI: 0.55–0.93, p < 0.029).
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ApHCM.
With the electrocardiographic changes, some investi-
gators found that the late and abrupt development of
ApHCM occurs at an elderly age [30-32]. The late de-
velopment of ApHCM in the elderly may indicate a
gene-environment interaction required for phenotypic
manifestations. The “inducers” making the morphology
of ApHCM in the adult patients are not known. Hyper-
tension is associated with ApHCM, and its prevalences
in the previous study cohort were 51%–67% [7,32]
which is higher than that of the general population [33].
Although it is difficult to prove causality, this raises the
possible role of sustained hypertension as an inducer of
ApHCM. Therefore, we used hypertension as a baseline
comorbidity to study the mechanical effect of ApHCM on
left ventricular systolic deformation. Based on the presence
of early left ventricular mechanic abnormalities in prehy-
pertension [34], further studies on whether the impact of
ApHCM on the left ventricle is localized to or extended
beyond the apex would provide more information to
understand left ventricular mechanics. Consistent with the
prior study on prehypertension and hypertension [34-36],
our study showed impaired basal and middle longitudinal
strains even in the well-controlled hypertensive patients.
With the presence of apical hypertrophy, the globallongitudinal and circumferential strains decreased further
although the blood pressure control was adequate. These
findings indicate that ApHCM might develop progressively
and incidentally even in the presence of well-controlled
hypertension. Only regular follow-up with electrocardiog-
raphy and/or echocardiography could identify these pa-
tients earlier.Limitations
First, the retrospective design limited data analyses in
the present investigation. Second, the number of patients
included in the present study was small. Further research
with a larger number of patients and a prospective design
are needed to confirm our findings. Third, this study was
conducted at a single tertiary center study. Therefore, our
study population might not represent all patients with
hypertension and ApHCM. Nonetheless, there are few if
any studies using 2-dimensional speckle-tracking echo-
cardiography for evaluating left ventricular mechanics in
hypertensive patients with ApHCM. Therefore, our results
provide valuable new insights into understanding the ef-
fects of pathological apical hypertrophy on left ventricular
function in patients with hypertension. Finally, the incom-
plete coverage of apical hypertrophy might limit the strain
analysis in patients with ApHCM.
Figure 4 Scatterplots (left panel) and Bland-Altman plots (right panel). Comparison between observers (inter- and intra-agreement) at the
left ventricular global longitudinal (A and B), circumferential (C and D), and radial strains (E and F). Ninety-five percent limits of agreement are
shown as 2 dotted lines in the right panel.
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ApHCM conferred a negative impact on left ventri-
cular function in hypertensive patients. Reduced apicallongitudinal and radial strains without a base-to-apex gra-
dient were present in hypertensive patients with ApHCM.
These alterations of myocardial strain are evidence of early
Kao et al. Cardiovascular Ultrasound 2013, 11:40 Page 11 of 12
http://www.cardiovascularultrasound.com/content/11/1/40contractile abnormalities in hypertensive patients with
ApHCM. Among the systolic parameters measured, the
global longitudinal strain was an independent predictor of
hypertension with ApHCM.
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